|
||||||||||||||||||||||||||
|
![]() ![]() Sepragen Successfully Completes Research Using a National Science Foundation Grant, to Advance Stem Cell BioreactorsJanuary 24th 2019, Union City, CA. Sepragen Corporation announced today it had successfully completed research using a grant from the National Science Foundation to demonstrate the feasibility of using a "wicking" matrix bioreactor (WMB) for expansion of hiPSCs for tissue engineering and regenerative medicine applications. "There aren’t any established devices or techniques for large scale growth and expansion of stem cells. This is deemed a limiting factor for commercial advancement in this promising field of regenerative medicine. Sepragen has been researching a highly innovative bioreactor for this sought after application" states Vinit Saxena, CEO of Sepragen. The unique bioreactor from Sepragen enables precision control of gassing conditions leading to potentially high viabilities of large cell populations with minimal spontaneous and uncontrolled differentiation. This grants targets the use of the bioreactor for growing beta islets cells. Sepragen was able to demonstrate proof-of-principal for the utility of the WMB for regenerative medicine applications. The work is being done at Sepragen’s Union City location. For more information Contact:
|
|||||||||||||||||||||||||
|